Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Bkemvbkemv.com · Low evidenceBKEMV is the first FDA-approved interchangeable eculizumab biosimilar to Soliris. It treats paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and generalized myasthenia gravis (gMG).
Parse Score
Sources
imarcgroup.com shapes more of what AI says about Bkemv than any other source, at 100% of its citations.